Clinical Trial Update: ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD) [Phase 3]

View source ↗

Summary

Phase 3 trial status update for subcutaneous elamipretide in dry age-related macular degeneration; the study is currently active but not recruiting, with assess…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Dry Age-related Macular Degeneration

Drugs mentioned

• Elamipretide (elamipretide)

Snippet

Sponsor: Stealth BioTherapeutics Inc. | Conditions: Age Related Macular Degeneration (ARMD) | Phase 3 | Status: ACTIVE_NOT_RECRUITING